Fluorescent substrates for soluble epoxide hydrolase and application to inhibition studies.

[1]  B. Hammock,et al.  Epoxide hydrolases: mechanisms, inhibitor designs, and biological roles. , 2005, Annual review of pharmacology and toxicology.

[2]  J. Pollock,et al.  Soluble epoxide hydrolase inhibition protects the kidney from hypertension-induced damage. , 2004, Journal of the American Society of Nephrology : JASN.

[3]  R. Schmid,et al.  Fluorometric assay for determining epoxide hydrolase activity , 2004, Biotechnology Letters.

[4]  B. Hammock,et al.  Design, synthesis, and biological activity of 1,3-disubstituted ureas as potent inhibitors of the soluble epoxide hydrolase of increased water solubility. , 2004, Journal of medicinal chemistry.

[5]  B. Hauer,et al.  Spectrophotometric assay for epoxide hydrolase activity toward any epoxide. , 2003, Analytical biochemistry.

[6]  B. Hammock,et al.  Design, synthesis and evaluation of novel P450 fluorescent probes bearing α-cyanoether , 2003 .

[7]  Å. Wheelock,et al.  Evaluation of α-cyanoesters as fluorescent substrates for examining interindividual variation in general and pyrethroid-selective esterases in human liver microsomes , 2003 .

[8]  R. Furstoss,et al.  A spectrophotometric assay for measuring and detecting an epoxide hydrolase activity. , 2003, Analytical biochemistry.

[9]  Nathan R. McElroy,et al.  QSAR and classification of murine and human soluble epoxide hydrolase inhibition by urea-like compounds. , 2003, Journal of medicinal chemistry.

[10]  C. Wheelock,et al.  Structural refinement of inhibitors of urea-based soluble epoxide hydrolases. , 2002, Biochemical pharmacology.

[11]  B. Hammock,et al.  Soluble Epoxide Hydrolase Inhibition Lowers Arterial Blood Pressure in Angiotensin II Hypertension , 2002, Hypertension.

[12]  B. Hammock,et al.  Development of Sensitive Esterase Assays Based on α-Cyano-Containing Esters , 2001 .

[13]  C. Brochu,et al.  Catalytic asymmetric cyclopropanation of allylic alcohols with titanium-TADDOLate: scope of the cyclopropanation reaction. , 2001, Journal of the American Chemical Society.

[14]  I. Fleming,et al.  Sphingolipid Mediators in Cardiovascular Cell Biology and Pathology , 2022 .

[15]  I. Fleming.  Cytochrome P450 Enzymes in Vascular Homeostasis , 2001 .

[16]  B D Hammock,et al.  Soluble Epoxide Hydrolase Regulates Hydrolysis of Vasoactive Epoxyeicosatrienoic Acids , 2000, Circulation research.

[17]  J. Reymond,et al.  A Versatile Periodate-Coupled Fluorogenic Assay for Hydrolytic Enzymes , 2000 .

[18]  B D Hammock,et al.  3-D QSAR analysis of inhibition of murine soluble epoxide hydrolase (MsEH) by benzoylureas, arylureas, and their analogues. , 2000, Bioorganic & medicinal chemistry.

[19]  B. Hammock,et al.  Metabolism of monoepoxides of methyl linoleate: bioactivation and detoxification. , 2000, Archives of biochemistry and biophysics.

[20]  J. Falck,et al.  Cytochrome P450 and arachidonic acid bioactivation. Molecular and functional properties of the arachidonate monooxygenase. , 2000, Journal of lipid research.

[21]  R. Busse,et al.  Cytochrome P450 2C is an EDHF synthase in coronary arteries , 1999, Nature.

[22]  B D Hammock,et al.  Potent urea and carbamate inhibitors of soluble epoxide hydrolases. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[23]  N. Weintraub,et al.  Epoxyeicosatrienoic acids and dihydroxyeicosatrienoic acids are potent vasodilators in the canine coronary microcirculation. , 1998, Circulation research.

[24]  N. Sampson,et al.  The importance of GLU361 position in the reaction catalyzed by cholesterol oxidase. , 1998, Bioorganic & medicinal chemistry letters.

[25]  B D Hammock,et al.  Mechanism of mammalian soluble epoxide hydrolase inhibition by chalcone oxide derivatives. , 1998, Archives of biochemistry and biophysics.

[26]  B. Hammock,et al.  Bioactivation of leukotoxins to their toxic diols by epoxide hydrolase , 1997, Nature Medicine.

[27]  F. Oesch,et al.  Sequence similarity of mammalian epoxide hydrolases to the bacterial haloalkane dehalogenase and other related proteins , 1994, FEBS letters.

[28]  E. Dietze,et al.  Spectrophotometric substrates for cytosolic epoxide hydrolase. , 1994, Analytical biochemistry.

[29]  B. Hammock,et al.  cDNA cloning and expression of a soluble epoxide hydrolase from human liver. , 1993, Archives of biochemistry and biophysics.

[30]  B. Hammock,et al.  Molecular cloning and expression of murine liver soluble epoxide hydrolase. , 1993, The Journal of biological chemistry.

[31]  D. Zeldin,et al.  Regio- and enantiofacial selectivity of epoxyeicosatrienoic acid hydration by cytosolic epoxide hydrolase. , 1993, The Journal of biological chemistry.

[32]  B D Hammock,et al.  Affinity purification of cytosolic epoxide hydrolase using derivatized epoxy-activated Sepharose gels. , 1988, Analytical biochemistry.

[33]  N. Ragoussis.  Modified knoevenagel condensations. Synthesis of (E)-3-alkenoic acids. , 1987 .

[34]  R. K. Olsen,et al.  Esterification of N-protected .alpha.-amino acids with alcohol/carbodiimide/4-(dimethylamino)pyridine. Racemization of aspartic and glutamic acid derivatives , 1982 .

[35]  R. K. Olsen,et al.  ESTERIFICATION OF N-PROTECTED α-AMINO ACIDS WITH ALCOHOL/CARBODIIMIDE/4-(DIMETHYLAMINO)PYRIDINE. RACEMIZATION OF ASPARTIC AND GLUTAMIC ACID DERIVATIVES , 1982 .

[36]  F. Oesch,et al.  Mammalian epoxide hydrases: inducible enzymes catalysing the inactivation of carcinogenic and cytotoxic metabolites derived from aromatic and olefinic compounds. , 1973, Xenobiotica; the fate of foreign compounds in biological systems.